Skip to main content
. Author manuscript; available in PMC: 2023 Feb 1.
Published in final edited form as: Pediatr Cardiol. 2021 Sep 14;43(2):366–372. doi: 10.1007/s00246-021-02730-x

Table 2.

Impact of calcium chloride infusions on postoperative outcomes, univariate analysis

Calcium Group (n = 66) Control Group (n = 69) p value
Systolic blood pressure
   Admission to ICU 81 (72, 94) 80 (72, 90)    0.45
   6 h 70 (63, 77) 72 (66, 79)    0.25
   12 h 70 (65, 75) 73 (66, 78)    0.12
   24 h 71 (68, 77) 73 (67, 82)    0.40
Diastolic blood pressure
   Admission to ICU 49 (43, 57) 47 (40, 55)    0.41
   6 h 46 (42, 50) 47 (43, 51)    0.72
   12 h 45 (40, 51) 45 (40, 51)    0.97
   24 h 43 (39, 49) 45 (39, 50)    0.84
Heart rate
   Admission to the ICU 157 (150, 167) 161 (148, 176)    0.27
   6 h 169 (150, 176) 165 (150, 179)    0.95
   12 h 167 (157, 176) 169 (151, 179)    0.62
   24 h 157 (149, 171) 159 (147, 168)    0.54
Cerebral NIRS
   Admission to the ICU 53 ± 12 55 + 16    0.48
   6 h 55 ± 12 57 ± 14    0.61
   12 h 59 ± 12 58 ± 13    0.61
   24 h 64 ± 13 63 ± 14    0.85
Lactate
   Admission to the ICU 2.6 (2.0, 3.6) 2.0 (1.5, 3.3)    0.01
   6 h 2.5 (1.4, 3.3) 1.5 (1.1, 2.4)    < 0.01
   12 h 2.3 (1.6, 3.0) 1.7 (1.2, 2.4)    < 0.01
   24 h 1.5 (1.0, 2.0) 1.6 (1.0, 2.3)    0.65
Vasoactive Inotropic Score (VIS)
   Admission to the ICU 10.5 + 4.7 10.1 ± 6.1    0.70
   6 h 13.6 ± 5.9 12.4 ± 6.8    0.28
   12 h 12.6 ± 6.1 12.9 ± 6.8    0.28
   24 h 13.1 ± 5.8 11.5 ± 6.7    0.16
   Max 17.3 ± 6.0 14.9 ± 7.3    0.04
VIS > 10 56 (90%) 51 (74%)    0.02
CPB patients onlya 53 (88%) 44 (92%)    0.75
Maximum VIS > 15 42 (70%) 38 (55%)    0.08
CPB patients onlyb 39 (65%) 33 (69%)    0.84
Renal injuryc 2 (3%) 3 (4%)    1.0
Acute liver injuryd 6 (10%) 5 (8%)    0.76
ECMO 5 (8%) 8 (12%)    0.57
Cardiac arrest 5 (8%) 6 (9%)    1.0
Duration of postoperative ventilation (days) 4 (3, 7) 4 (2, 8)    0.93
Time to postoperative feed initiation (days) 4 (3, 5) 3 (2, 5)    0.11
Hospital LOS (days) 37 (25, 53) 33 (21, 54)    0.29
Operative mortality 4 (6%) 8 (12%)    0.37
Composite outcome 24 (39%) 24 (35%)    0.72

Categorical data are presented as n (%). Continuous data are presented as mean (standard deviation) for data that are normally distributed or median (interquartile range) for data that are not normally distributed

CPB cardiopulmonary bypass, ICU intensive care unit, NIRS near-infrared spectroscopy, VIS vasoactive inotropic score, ECMO extracorporeal membrane oxygenation, LOS length of stay

a

Denominator for patients who received CPB and calcium infusion = 60

b

Denominator for patients who received CPB and no calcium infusion = 48

c

Denominator for renal injury and calcium group = 62, denominator for control group = 69

d

Denominator for acute liver injury and calcium group = 60, denominator for control group = 63